A basics guide to genomic testing: Metastatic breast cancer

Описание: In metastatic breast cancer, the cancer can change as it spreads to other parts of your body. Genomic testing is a type of biomarker testing used to help understand how the cancer has changed and can help with decision-making about what treatment to try – or not try – next. Dr. Angela DeMichele shares what to know before getting biomarker testing, why these tests are recommended, and what kind of information they can provide about a tumor. She also explains the importance of getting genetic testing and participating in clinical trials.

About our speaker:
Angela DeMichele, MD, MSCE, is a member of LBBC's medical advisory board and a professor of medicine and epidemiology at the University of Pennsylvania, focusing on breast cancer oncology and molecular epidemiology. She is a senior scholar in the Center for Clinical Epidemiology and Biostatistics at the University of Pennsylvania, as well as the co-director of the breast cancer program at the Abramson Cancer Center.

Learn more about Dr. DeMichele: https://www.lbbc.org/about-us/medical...

Learn more about biomarker testing in metastatic breast cancer: https://www.lbbc.org/about-breast-can...

Chapters:
00:00 - 00:23 Intro
00:24 - 02:40 Biomarker testing in MBC
02:41 - 04:17 How biomarker tests affect treatment
04:18 - 05:37 Genetic mutations
05:38 - 06:32 Why are biomarker tests recommended?
06:33 - 07:26 What if I don't test positive?
07:27 - 09:03 Participating in clinical trials
09:04 - 10:38 What to know before testing

#BiomarkerTesting #GenomicTesting #metastaticbreastcancer

At Living Beyond Breast Cancer, we make sure people facing breast cancer have the support they need. We’re here with real answers, real stories, and real help—every step of the way.

Follow us:
Facebook:   / livingbeyondbreastcancer  
LinkedIn:   / living-beyond-breast-cancer  
Instagram:   / livingbeyondbc  
YouTube:    / lbbc1991